Safety and Efficacy of Recombinant Activated Factor VII (Novoseven) Administration in Pediatric ECMO Patients

被引：1
|
作者：
Kasniya, G. [1 ]
Salisbury, C. [2 ]
Heard, M. L. [2 ]
Maher, K. [3 ]
Deshpande, S. R. [3 ]
机构：
[1] Childrens Healthcare Atlanta, Pediat Cardiol, Atlanta, GA USA
[2] Childrens Healthcare Atlanta, Atlanta, GA USA
[3] Emory Univ, Childrens Healthcare Atlanta, Pediat Cardiol, Atlanta, GA 30322 USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2016年 / 35卷 / 04期
关键词：
D O I：
10.1016/j.healun.2016.01.1217
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1183
引用
收藏
页码：S421 / S422
页数：2
相关论文
共 50 条
  • [21] Pulmonary administration of activated recombinant factor VII
    Grochova, M.
    Kalnasova, B.
    Firment, J.
    Olejarova, I
    Roland, R.
    Lazurova, I
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2011, 112 (01): : 29 - 33
  • [22] Successful treatment of Glanzmann's Thrombasthenia with recombinant activated Factor VII "NovoSeven"
    Keikhaei, Bijan
    HAEMOPHILIA, 2014, 20 : 101 - 102
  • [23] Small-dose recombinant activated factor VII (NovoSeven®) in cardiac surgery
    Romagnoli, S
    Bevilacqua, S
    Gelsomino, S
    Pradella, S
    Ghilli, L
    Rostagno, C
    Gensini, GF
    Sorbara, C
    ANESTHESIA AND ANALGESIA, 2006, 102 (05): : 1320 - 1326
  • [24] Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review
    Long, M. T.
    Wagner, D.
    Maslach-Hubbard, A.
    Pasko, D. A.
    Baldridge, P.
    Annich, G. M.
    PERFUSION-UK, 2014, 29 (02): : 163 - 170
  • [25] The effect of the administration of recombinant activated factor VII (NovoSeven®) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy:: the PROSE study
    Friederich, PW
    Geerdink, MGF
    Spataro, M
    Messelink, EJ
    Henny, CP
    Büller, HR
    Levi, M
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S129 - S132
  • [26] Management of 2 patients with subdural hematoma and Coagulopathy with recombinant human activated Factor VII (Novoseven, rVIIa).
    Abu-Hajir, M
    Hollowell, J
    Nagargoje, G
    BLOOD, 2001, 98 (11) : 79B - 79B
  • [27] EVALUATION OF THE EFFICACY AND SAFETY OF A HUMAN RECOMBINANT ACTIVATED FACTOR VII (HRFVIIA) PREPARATION IN A PEDIATRIC PATIENT WITH GLANZMANN THROMBASTHENIA
    Szamosujvari, J.
    Losonczy, G.
    Muszbek, L.
    Kappelmayer, J.
    Kiss, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 526 - 527
  • [28] Efficacy and Safety of Recombinant Activated Factor VII Off-label Use in a Pediatric Hematology/Oncology Cohort
    Shayeb, Akram Mesleh
    Su, Yin
    Kang, Guolian
    Elbahlawan, Lama
    Reiss, Ulrike M.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (02) : E72 - E78
  • [29] Use of recombinant activated factor vii in pediatric patients without hemophilia
    Muwakkit, S. A.
    Majdalani, M. M.
    Musallem, K. M.
    Saab, R.
    Abboud, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 858 - 858
  • [30] Safety and preliminary efficacy of activated recombinant factor VII in acute intracerebral hemorrhage
    Mayer, S
    Brun, N
    STROKE, 2003, 34 (01) : 242 - 243
12345